97 related articles for article (PubMed ID: 36660177)
1. Gabapentinoid Prescribing for Carpal Tunnel Syndrome.
Billig JI; Gunaseelan V; Yazdanfar M; Sears ED; Iwashyna TJ; Chang T; Waljee JF
Hand (N Y); 2023 Jan; 18(1_suppl):106S-113S. PubMed ID: 35225033
[TBL] [Abstract][Full Text] [Related]
2. Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth.
McAnally H; Bonnet U; Kaye AD
Pain Ther; 2020 Dec; 9(2):441-452. PubMed ID: 32737803
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
Knowles GM; LaFleur GE; Churchwell MD
J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
[No Abstract] [Full Text] [Related]
4. Characterizing Gabapentinoid Use Among Patients With Isolated Low Back Pain.
Maloy GC; Halperin SJ; Ratnasamy PP; Grauer JN
Global Spine J; 2024 Jan; ():21925682231224390. PubMed ID: 38270402
[TBL] [Abstract][Full Text] [Related]
5. Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology.
Durand L; O'Kane A; Tierney J; Cronly M; Bennett KE; Kavanagh Y; Keenan E; Cousins G
Br J Clin Pharmacol; 2024 Apr; 90(4):987-995. PubMed ID: 38072974
[TBL] [Abstract][Full Text] [Related]
6. Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study.
Oh J; Yeo J
Korean J Pain; 2024 Jan; 37(1):73-83. PubMed ID: 38130090
[TBL] [Abstract][Full Text] [Related]
7. Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease : A Population-Based Cohort Study.
Rahman AA; Dell'Aniello S; Moodie EEM; Durand M; Coulombe J; Boivin JF; Suissa S; Ernst P; Renoux C
Ann Intern Med; 2024 Feb; 177(2):144-154. PubMed ID: 38224592
[TBL] [Abstract][Full Text] [Related]
8. Patterns of gabapentinoid use among long-term opioid users.
Westra J; Raji M; Baillargeon J; Aparasu RR; Kuo YF
Prev Med; 2024 Jun; ():108046. PubMed ID: 38897356
[TBL] [Abstract][Full Text] [Related]
9. Gabapentinoid prescriptions for neuropathic and musculoskeletal pain in Lebanon.
Rassi J; Khazaka S; Hlais S; Rassi S; Daher M; Samaha T
Future Sci OA; 2024; 10(1):FSO960. PubMed ID: 38817381
[TBL] [Abstract][Full Text] [Related]
10. Risk of respiratory depression with opioids and concomitant gabapentinoids.
Savelloni J; Gunter H; Lee KC; Hsu C; Yi C; Edmonds KP; Furnish T; Atayee RS
J Pain Res; 2017; 10():2635-2641. PubMed ID: 29180889
[TBL] [Abstract][Full Text] [Related]
11. Update to Gabapentinoid Use in the United States, 2002-2021.
Johansen ME; Maust DT
Ann Fam Med; 2024; 22(1):45-49. PubMed ID: 38253511
[TBL] [Abstract][Full Text] [Related]
12. A snapshot on the usage pattern of gabapentinoids in Oman.
Badi ASA; Hashar AA; Riyami IA; Za'abi MA
Pharm Pract (Granada); 2022; 20(3):2693. PubMed ID: 36733519
[TBL] [Abstract][Full Text] [Related]
13. A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies.
İspir GZ; Danışman M; Katar KS
Curr Drug Res Rev; 2023 Nov; ():. PubMed ID: 38031769
[TBL] [Abstract][Full Text] [Related]
14. Gabapentinoids: a therapeutic review.
Athavale A; Murnion B
Aust Prescr; 2023 Dec; 46(4):80-85. PubMed ID: 38152314
[TBL] [Abstract][Full Text] [Related]
15. Mirogabalin, a selective gabapentinoid for managing neuropathic pain-A curtain raiser.
Nair A
J Anaesthesiol Clin Pharmacol; 2022; 38(4):691-692. PubMed ID: 36778825
[No Abstract] [Full Text] [Related]
16. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.
Meaadi J; Obara I; Eldabe S; Nazar H
Int J Clin Pharm; 2023 Jun; 45(3):556-565. PubMed ID: 36848024
[TBL] [Abstract][Full Text] [Related]
17. Gabapentinoid Prescribing Practices at a Large Academic Medical Center.
Huang LL; Wright JA; Fischer KM; Croghan IT; Nanda S; Schroeder DR; Vincent A
Mayo Clin Proc Innov Qual Outcomes; 2023 Feb; 7(1):58-68. PubMed ID: 36660177
[TBL] [Abstract][Full Text] [Related]
18. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
19. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
